Vericel Corp Quarterly Depreciation in USD from Q2 2014 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vericel Corp quarterly/annual Depreciation history and growth rate from Q2 2014 to Q4 2024.
  • Vericel Corp Depreciation for the quarter ending December 31, 2024 was $1.3M, a 30% increase year-over-year.
  • Vericel Corp Depreciation for the twelve months ending December 31, 2024 was $4.9M, a 22.5% increase year-over-year.
  • Vericel Corp annual Depreciation for 2024 was $4.9M, a 22.5% increase from 2023.
  • Vericel Corp annual Depreciation for 2023 was $4M, unchanged from 2022.
  • Vericel Corp annual Depreciation for 2022 was $4M, a 33.3% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $4.9M $1.3M +$300K +30% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $4.6M $1.2M +$200K +20% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.4M $1.2M +$200K +20% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $4.2M $1.2M +$200K +20% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $4M $1M $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $4M $1M $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $4M $1M -$100K -9.09% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $4.1M $1M +$100K +11.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $4M $1M +$200K +25% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $3.8M $1M +$300K +42.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $3.5M $1.1M +$400K +57.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $3.1M $900K +$100K +12.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $3M $800K +$17K +2.17% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $2.98M $700K +$100K +16.7% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $2.88M $700K +$200K +40% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $2.68M $800K +$300K +60% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $2.38M $783K +$139K +21.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $2.24M $600K +$200K +50% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.04M $500K +$100K +25% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.94M $500K +$200K +66.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $1.74M $644K Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $400K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $400K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $300K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2015 $400K +$200K +100% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $200K +$100K +100% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-12
Q3 2014 $200K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $100K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.